Related Experiment Video
Updated: Jan 6, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
The role of chimeric FAM72B transcripts generated by intergenic mRNA trans-splicing in breast cancer
Gangotri Patra1, Pok-Son Kim2, Arne Kutzner3
1Graduate School of Biomedical Science and Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.
Abstract:
Family with sequence similarity 72 (FAM72) is a protein-coding gene family located on chromosome 1 (chr1) in humans, and its functional roles, particularly in cancer, remain incompletely understood. Chimeric messenger RNA (mRNA) generated by intergenic mRNA trans-splicing (CRTS) is a novel phenomenon increasingly recognized for its involvement in cancer biology. It involves the fusion of two separate mRNA transcripts from different genomic loci, resulting in a chimeric mRNA molecule with altered functions. Since aging-related diseases, including various types of cancer, are major threats to our society, we investigated the functional significance of chimeric FAM72 fusion genes and their potential role in cancer cell proliferation with a focus on intergenic mRNA trans-splicing of FAM72 in cancer. We applied biocomputational analyses to identify chimeric FAM72 fusion genes across various cancer tissues. Whole-genome sequencing (WGS) and next-generation sequencing (NGS) of mRNA (RNA-seq) analysis were applied to identify novel chimeric FAM72 fusion genes at the genome (genomic structural variants or SVs) and/or mRNA level (trans-splicing). Our data supported the occurrence of novel chimeric adiponectin receptor-2 (ADIPOR2) :: FAM72B mRNA transcripts primarily produced through an intergenic mRNA trans-splicing event. Afterwards, we set up a breast cancer tissue-specific cell system to analyze the proliferative and migratory efficacy of cancer cells expressing these novel chimeric ADIPOR2::FAM72B mRNA fusion transcripts. Our findings suggest that the novel chimeric ADIPOR2::FAM72B mRNAs, generated by intergenic mRNA trans-splicing, can act as oncogenic drivers and represent promising diagnostic and therapeutic targets in breast cancer.
Insights
Novel chimeric ADIPOR2::FAM72B mRNA, formed by trans-splicing, drives cancer cell proliferation. These fusion transcripts are promising diagnostic and therapeutic targets for breast cancer.
Area of Science:
- Genomics and Cancer Biology
- Molecular Oncology
- Gene Expression Regulation
Background:
- The functional roles of the Family with sequence similarity 72 (FAM72) gene family in cancer are not fully understood.
- Chimeric messenger RNAs (mRNAs) generated by intergenic mRNA trans-splicing (CRTS) are emerging as significant players in cancer biology.
- Aging-related diseases, including various cancers, pose substantial societal threats, necessitating research into their underlying molecular mechanisms.
Purpose of the Study:
- To investigate the functional significance of chimeric FAM72 fusion genes in cancer cell proliferation.
- To explore the role of intergenic mRNA trans-splicing involving FAM72 in cancer.
- To identify novel chimeric FAM72 fusion genes and their oncogenic potential.
Main Methods:
- Biocomputational analyses were employed to detect chimeric FAM72 fusion genes across diverse cancer tissues.
- Whole-genome sequencing (WGS) and next-generation sequencing of mRNA (RNA-seq) were utilized to identify genomic structural variants (SVs) and trans-splicing events.
- A breast cancer tissue-specific cell system was established to assess the impact of chimeric transcripts on cancer cell proliferation and migration.
Main Results:
- The study identified novel chimeric adiponectin receptor-2 (ADIPOR2)::FAM72B mRNA transcripts, predominantly generated via intergenic mRNA trans-splicing.
- Expression of these chimeric ADIPOR2::FAM72B mRNA fusion transcripts was shown to enhance cancer cell proliferation and migration.
- The identified chimeric transcripts were found to be associated with breast cancer tissues.
Conclusions:
- The novel chimeric ADIPOR2::FAM72B mRNAs, resulting from intergenic mRNA trans-splicing, function as oncogenic drivers.
- These chimeric transcripts represent potential diagnostic biomarkers and therapeutic targets for breast cancer.
- Further research into FAM72-related trans-splicing events could uncover new avenues for cancer treatment.
More Related Videos
Related Concept Videos
RNA Splicing
MicroRNAs
MicroRNAs
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Leaky Scanning

